CHTR vs TERN · P/E 11, rev $55.09B vs $6.12B cap
Charter Communications Inc (CHTR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CHTR and TERN stock pages for the full models.
Not investment advice.